International Isotopes completes $5.8M in private placement

International Isotopes has completed a private placement that will immediately provide the company with approximately $5.8 million in cash to continue its efforts on the licensing and design of its planned uranium de-conversion and fluorine extraction processing facility.

Euro Pacific Capital served as the sole placement agent for the private placement. Under the terms of the Securities Purchase Agreement, accredited investors purchased 29,075,000 units for $0.20 per unit, according to the Idaho Falls, Idaho-based company.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.